Advertisement
Screener

NEXTCURE, INC (NXTC) Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

1.4 / 5 stars · 8/29 Roast Me

NEXTCURE, INC Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

NEXTCURE, INC (NXTC) had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $8.03 million as of 2025-12-31, per its S-4 filed 2026-08-18.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2026-08-18

  • 2025-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $8.03M.
  • 2024-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $7.23M.
  • 2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $6.05M.
  • 2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.39M.
Period endDeferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost
2025-12-31$8.03M
S-4 · filed 2026-08-18
2024-12-31$7.23M
S-4 · filed 2026-08-18
2023-12-31$6.05M
10-K · filed 2025-03-06
2022-12-31$4.39M
10-K · filed 2024-03-21
2021-12-31$3.18M
10-K · filed 2023-03-02
2020-12-31$1.78M
10-K · filed 2022-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
AYTU BIOPHARMA, INC (AYTU)United States$0.025B-1.62
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
Cocrystal Pharma, Inc. (COCP)United States$0.022B
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Marker Therapeutics, Inc. (MRKR)United States$0.020B-2.86